Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter Equipment

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1330300

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1330300

Vascular Access Device Market by Type (Central, Peripheral ), Application, End User &Region - Global Forecast to 2028

PUBLISHED:
PAGES: 188 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

The global vascular access device market is projected to reach USD 7.9 billion by 2028 from USD 5.6 billion in 2023, at a CAGR of 7.0% during the forecast period. Growth in the vascular access device market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, and growing use of vascular access device in pediatric patients. However, the high cost involved in the placement and maintenance of vascular access device is expected to limit the growth of the vascular access device market to a certain extent during the forecast period.

In 2023, the central vascular access device segment is projected to account for the largest share of the vascular access device market

By type, vascular access device market is segmented into there are peripheral access device, central vascular access device, and accessories holding a significant portion. The central vascular access device segment is is projected to account for the largest share of the global vascular access device market in 2023. Factors such as broad usage of central vascular access device in chemotherapy and in the medication of cardiovascular disorders and chronic kidney disorders.

Drug administration is projected to account for the largest share of the vascular access device market in 2023

By application, vascular access device market is segmented into drug administration, fluid and nutrition administration,blood transfusion, and diagnostic & testing. The drug administration segment is is projected to account for the largest share of the global vascular access device market in 2023.Factors such as high use of vascular access device for drug administration, specially for the treatment of infections and cancer are driving the market growth.

By end user, hospitals accounted for the largest share of the market in 2022

By end users, vascular access device market is segmented into hospitals, clinics & ambulatory centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). In 2022, hospitals accounted for the largest market share. Factors suc as majority of vascular procedures are performed in hospital settings and also emergency care in hospitals needs VADs for blood transfusion and administration of various drugs.

By region, North America is projected to account for the largest share of the vascular access device market

By region,North America accounted for the largest share of the vascular access device market in 2023. Factors such as the presence of key players, a supportive reimbursement framework, and significant government investments in cutting-edge medical devices,rising healthcare costs, government initiatives, and an increase in disposable income are contributing to the market's growth in North America.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-55%, Tier 2-25%, and Tier 3-20%
  • By Designation - C-level-43%, Director-level-32%, Others-25%
  • By Region - North America-38%, Europe-23%, Asia Pacific-29%, Rest of the World- 10%

Key players in the vascular access device Market

The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), Nipro Medical Corporation (Japan), Medtronic (Ireland), Amecath (Egypt),Romsons (India), PRODIMED (France),Cook Medical (US), Access Vascular, Inc. (US), Medical Components, Inc. (US), Vygon (France), 3M (US), Argon Medical Devices (US), Guangdong Baihe Medical Technology Co., Ltd. (China), pfm medical (Germany), Medi-Tech Devices Pvt Ltd (India), Medline Industries, LP (US), Kimal (UK), Deltamed (Italy), Newtech Medical Devices (India) and Shanghai Puyi Medical Instruments Co., Ltd (China).

Research Coverage:

The report analyzes the vascular access device Market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application and end user. The report also includes a product portfolio matrix of various vascular access device products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

Analysis of key drivers (growing prevalence of lifestyle diseases,increasing number of chemotherapy procedures,increasing use of vascular access device in pediatric patients), restraints (high costs involved in the placement and maintenance of vascular access device,product recalls and failures), opportunities (technological advancements and growth in the number of hospitals) and challenges (Shortage of skilled professionals and risks associated with vascular access device) influencing the growth of vascular access device market.

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global vascular access device Market. The report analyzes this market by type, applications and end user.
  • Service Enhancement/Innovation: Detailed insights on upcoming trends in the global vascular access device Market
  • Market Development: Comprehensive information on the lucrative emerging markets by applications, type and end user.
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global vascular access device Market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, company evaluation quadrant, and capabilities of leading players in the global vascular access device Market.
Show more
Product Code: MD 5434

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 VASCULAR ACCESS DEVICES MARKET SEGMENTATION
    • 1.2.3 REGIONAL SEGMENTATION
    • 1.2.4 YEARS CONSIDERED
  • 1.3 CURRENCY
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY
    • FIGURE 7 SEGMENTAL EXTRAPOLATION: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022)
    • FIGURE 8 BOTTOM-UP APPROACH: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022)
    • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 10 CAGR PROJECTIONS
    • FIGURE 11 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • 2.4 STUDY ASSUMPTIONS
  • 2.5 LIMITATIONS
    • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 VASCULAR ACCESS DEVICES MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 13 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW
    • FIGURE 17 GROWING PREVALENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER
    • FIGURE 18 HOSPITALS ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022
  • 4.3 VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET (2021-2028)
    • FIGURE 20 ASIA PACIFIC MARKET TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
  • 4.5 VASCULAR ACCESS DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES
    • FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of lifestyle diseases
      • 5.2.1.2 Increasing number of chemotherapy procedures
      • 5.2.1.3 Growing use of vascular access devices in pediatric patients
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost associated with placement and maintenance of vascular access devices
      • 5.2.2.2 Product recalls and failures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Technological advancements
      • 5.2.3.2 Growth in number of hospitals
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals
      • 5.2.4.2 Risks associated with vascular access devices
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
    • 5.3.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 23 MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 ECOSYSTEM MAPPING
    • 5.5.1 ROLE IN ECOSYSTEM
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.6.3 BARGAINING POWER OF BUYERS
    • 5.6.4 BARGAINING POWER OF SUPPLIERS
    • 5.6.5 THREAT OF SUBSTITUTES

6 VASCULAR ACCESS DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 1 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 6.2 CENTRAL VASCULAR ACCESS DEVICES
    • TABLE 2 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 3 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS
      • 6.2.1.1 Complications associated with PICCs to limit adoption in coming years
    • TABLE 4 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 TUNNELED CATHETERS
      • 6.2.2.1 Advantages of tunneled catheters such as lower risk of infection and lower chances of accidental removal to boost demand
    • TABLE 5 TUNNELED CATHETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 NON-TUNNELED CATHETERS
      • 6.2.3.1 High risk of infection to limit market growth
    • TABLE 6 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 IMPLANTED PORTS
      • 6.2.4.1 Lowest risk of infection associated with implanted ports to support growth
    • TABLE 7 IMPLANTED PORTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 PERIPHERAL VASCULAR ACCESS DEVICES
    • TABLE 8 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 9 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.1 PERIPHERAL SHORT DEVICES
      • 6.3.1.1 Ability of peripheral short devices to only administer select types of medication to hamper growth
    • TABLE 10 PERIPHERAL SHORT DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 PERIPHERAL MIDLINE DEVICES
      • 6.3.2.1 Need for trained nurses for procedures to restrict growth
    • TABLE 11 PERIPHERAL MIDLINE DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 BUTTERFLY/WINGED STEEL NEEDLES
      • 6.3.3.1 Wide usage of winged steel needles in blood sampling and diagnosis to propel growth
    • TABLE 12 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 ACCESSORIES
    • 6.4.1 RECURRENT NEED FOR ACCESSORIES TO BOOST MARKET
    • TABLE 13 VASCULAR ACCESS DEVICE ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 7.2 DRUG ADMINISTRATION
    • 7.2.1 HIGH USAGE OF VASCULAR ACCESS DEVICES FOR DRUG ADMINISTRATION TO BOOST SEGMENTAL GROWTH
    • TABLE 15 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 FLUID & NUTRITION ADMINISTRATION
    • 7.3.1 GROWING USE OF PERIPHERAL VASCULAR ACCESS DEVICES FOR SHORT-TERM NUTRITIONAL THERAPY TO SUPPORT MARKET
    • TABLE 16 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 BLOOD TRANSFUSION
    • 7.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION IN TREATMENT OF VARIOUS CONDITIONS TO BOOST GROWTH
    • TABLE 17 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 DIAGNOSTICS & TESTING
    • 7.5.1 GROWING POPULARITY OF PERIPHERAL LINES FOR DIAGNOSTIC & TESTING APPLICATIONS TO DRIVE MARKET GROWTH
    • TABLE 18 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

8 VASCULAR ACCESS DEVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 19 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 HIGH DEMAND FOR VASCULAR ACCESS DEVICES IN HOSPITAL SETTINGS TO BOOST MARKET
    • TABLE 20 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 CLINICS & AMBULATORY CARE CENTERS
    • 8.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
    • TABLE 21 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 22 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

9 VASCULAR ACCESS DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 23 VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
    • TABLE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 26 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 28 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 29 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 High prevalence of chronic diseases to drive market growth
    • TABLE 30 INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED
    • TABLE 31 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 32 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 33 US: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 34 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 35 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Increasing number of minimally invasive procedures to support market growth
    • TABLE 36 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 37 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 38 CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 39 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 40 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 EUROPE: RECESSION IMPACT
    • TABLE 41 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 43 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Growing geriatric and obese populations to contribute to market growth
    • TABLE 47 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 48 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 49 GERMANY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 50 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 51 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Increasing incidence of coronary heart disease to support market growth
    • TABLE 52 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 53 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 54 UK: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 56 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.4 FRANCE
      • 9.3.4.1 Strong government support and favorable strategies & initiatives to drive market growth
    • TABLE 57 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 58 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 59 FRANCE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 61 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Strong healthcare policies by government to propel growth
    • TABLE 62 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 64 ITALY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 65 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 66 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Growing geriatric population to increase demand for vascular access devices
    • TABLE 67 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 68 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 SPAIN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 70 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 71 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 72 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 73 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 REST OF EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 76 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 25 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
    • TABLE 77 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Large geriatric population to support market growth
    • TABLE 83 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 84 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 85 JAPAN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 86 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 87 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.3 CHINA
      • 9.4.3.1 Growing target patient population to drive market growth
    • TABLE 88 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 CHINA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 92 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing prevalence of diabetes to drive adoption of vascular access devices
    • TABLE 93 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 INDIA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 96 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 97 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 98 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 100 REST OF ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 101 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 102 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • 9.5.1 REST OF THE WORLD: RECESSION IMPACT
    • TABLE 103 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 REST OF THE WORLD: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 REST OF THE WORLD: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 107 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 108 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2020-2022)
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2022)
  • 10.5 MARKET RANKING ANALYSIS
    • FIGURE 28 VASCULAR ACCESS DEVICES MARKET: KEY PLAYER RANKING, 2022
  • 10.6 COMPANY EVALUATION MATRIX
    • 10.6.1 STARS
    • 10.6.2 EMERGING LEADERS
    • 10.6.3 PERVASIVE PLAYERS
    • 10.6.4 PARTICIPANTS
    • FIGURE 29 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
  • 10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS
    • 10.7.1 PROGRESSIVE COMPANIES
    • 10.7.2 DYNAMIC COMPANIES
    • 10.7.3 STARTING BLOCKS
    • 10.7.4 RESPONSIVE COMPANIES
    • FIGURE 30 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022)
  • 10.8 COMPANY FOOTPRINT ANALYSIS
    • TABLE 109 COMPANY FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)
    • 10.8.1 COMPANY FOOTPRINT, BY TYPE
    • TABLE 110 TYPE FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)
    • 10.8.2 COMPANY FOOTPRINT, BY REGION
    • TABLE 111 REGIONAL FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES
    • TABLE 112 PRODUCT LAUNCHES, JANUARY 2019-JULY 2023
    • 10.9.2 DEALS
    • TABLE 113 DEALS, JANUARY 2019-JULY 2023
    • 10.9.3 OTHER DEVELOPMENTS
    • TABLE 114 OTHER DEVELOPMENTS, JANUARY 2019-JULY 2023

11 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **
  • 11.1 KEY PLAYERS
    • 11.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 115 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 11.1.2 TELEFLEX INCORPORATED
    • TABLE 116 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 32 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
    • 11.1.3 ICU MEDICAL, INC.
    • TABLE 117 ICU MEDICAL, INC.: BUSINESS OVERVIEW
    • FIGURE 33 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.4 B. BRAUN SE
    • TABLE 118 B. BRAUN SE: BUSINESS OVERVIEW
    • FIGURE 34 B. BRAUN SE: COMPANY SNAPSHOT (2022)
    • 11.1.5 ANGIODYNAMICS, INC.
    • TABLE 119 ANGIODYNAMICS, INC.: BUSINESS OVERVIEW
    • FIGURE 35 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.6 TERUMO CORPORATION
    • TABLE 120 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
    • 11.1.7 NIPRO MEDICAL CORPORATION
    • TABLE 121 NIPRO MEDICAL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.8 MEDTRONIC
    • TABLE 122 MEDTRONIC: BUSINESS OVERVIEW
    • FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT (2022)
    • 11.1.9 AMECATH
    • TABLE 123 AMECATH: BUSINESS OVERVIEW
    • 11.1.10 ROMSONS
    • TABLE 124 ROMSONS: BUSINESS OVERVIEW
    • 11.1.11 PRODIMED
    • TABLE 125 PRODIMED: BUSINESS OVERVIEW
    • 11.1.12 COOK MEDICAL
    • TABLE 126 COOK MEDICAL: BUSINESS OVERVIEW
    • 11.1.13 ACCESS VASCULAR, INC.
    • TABLE 127 ACCESS VASCULAR, INC.: BUSINESS OVERVIEW
    • 11.1.14 MEDICAL COMPONENTS, INC.
    • TABLE 128 MEDICAL COMPONENTS, INC.: BUSINESS OVERVIEW
    • 11.1.15 VYGON
    • TABLE 129 VYGON: BUSINESS OVERVIEW
  • 11.2 OTHER COMPANIES
    • 11.2.1 3M
    • 11.2.2 ARGON MEDICAL DEVICES
    • 11.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
    • 11.2.4 PFM MEDICAL
    • 11.2.5 MEDI-TECH DEVICES PVT. LTD.
    • 11.2.6 MEDLINE INDUSTRIES, LP
    • 11.2.7 KIMAL
    • 11.2.8 DELTA MED
    • 11.2.9 NEWTECH MEDICAL DEVICES
    • 11.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
  • *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!